Publications

Our Managing Director, Chris Winchester, walked 115 km along the Ridgeway this weekend to raise money for rare disease research. He and schoolfriend Justin Brooker set off from Princes Risborough at 7:30 on Saturday morning, and arrived in Avebury 60 hours later bruised and battered but happy.

Oxford PharmaGenesis showcased a broad range of HealthScience services throughout the ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) meeting, held 7–10 October in Barcelona, Spain. ECTRIMS is the world’s largest annual international conference devoted to basic and clinical research in multiple sclerosis (MS), with this year’s edition attended by more than 9000 […]

Duchenne muscular dystrophy (DMD) is a progressive and ultimately fatal genetic muscle wasting disease that affects approximately 1 in 3500 newborn boys.1 A fault in the dystrophin gene prevents the production of the protein dystrophin, which is important for muscle structure and function.

The experience and insights of Oxford PharmaGenesis into founding its office in Basel are highlighted in a feature in the September issue of Director magazine (the publication of the UK Institute of Directors). The feature focuses on UK company expansion into Switzerland and includes quotes from an interview with Dr Richard White, Commercial Director of […]

Today, employees at Oxford PharmaGenesis wore their jeans to support Jeans for Genes Day, helping to raise vital funds for children and families affected by genetic disorders. A ‘Bling my Jeans’ competition was held, which was adjudicated while staff enjoyed a delicious ‘all you can eat’ breakfast buffet.

Commercial Director of Oxford PharmaGenesis, Richard White, has completed the Prudential RideLondon-Surrey 100 cycle race to raise funds for VICTA (Visually Impaired Children Taking Action), a charity that supports blind and partially sighted children in the UK. Oxford PharmaGenesis matches donations raised by employees in events that support health-related causes.

Nearly 200 medical communications and pharma industry professionals worldwide tuned in yesterday to hear Oxford PharmaGenesis deliver a webinar on publication and communication of Real World Evidence (RWE). Commercial Director Richard White and Account Director Tim Koder presented the webinar as part the International Society of Medical Publications Professionals (ISMPP) online educational series, ISMPP University […]

Managing Director Chris Winchester and Commercial Director Richard White are proud to have represented Oxford PharmaGenesis as a winner of the Queen’s Awards for Enterprise 2015 at a reception at Buckingham Palace last night. The reception, hosted by the Queen and the Duke of Edinburgh, was attended by the Duke of York, Princess Eugenie of […]

Anthony Nolan, a charity dedicated to saving the lives of patients needing a stem cell transplant, visited us in our Oxford office today. Irina Evseeva, Head of Specialist Services, gave a presentation to employees showing the science behind patient and donor matching, and Karen Archer, Regional Register Development Manager was on-site to accept registrations and […]

Oxford PharmaGenesis was today presented with the Queen’s Award for Enterprise by the Lord-Lieutenant of Oxfordshire, Tim Stevenson OBE. The award was made in recognition of the company’s outstanding growth in overseas sales, which has more than doubled over the past 4 years, from £4.0 million in 2010 to £8.9 million in 2013.